CardioNet, Inc. Appoints Peter Ferola General Counsel and Senior Vice President, Corporate Development
February 10 2011 - 11:27AM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical
technology company with an initial focus on the diagnosis and
monitoring of cardiac arrhythmias, announced today the appointment
of Peter Ferola as General Counsel and Senior Vice President,
Corporate Development.
Mr. Ferola brings to CardioNet more than nineteen years of
progressive leadership experience in business management, legal
affairs and corporate governance. Mr. Ferola comes to CardioNet
from Nipro Diagnostics, Inc. (formerly Home Diagnostics, Inc.,
NASDAQ: HDIX), where he served as Vice President, General Counsel
and Secretary. Prior to joining Home Diagnostics, Mr. Ferola
worked as a corporate and securities attorney with Greenberg
Traurig LLP and with Dilworth Paxson, LLP in Washington, D.C.
focusing on mergers, acquisitions, public securities offerings and
corporate governance matters. From 1989 to 2002, Mr. Ferola
worked in executive management roles for an American Stock
Exchange-listed company, most recently serving as Vice
President - Administration and Corporate Secretary, overseeing
the Company’s administrative functions, legal matters and investor
relations. Mr. Ferola earned a Bachelor of Science and Juris
Doctor degree from Nova Southeastern University and a Master of
Laws in Securities and Financial Regulation from Georgetown
University Law Center. Mr. Ferola has authored numerous
articles on corporate and securities laws, with a particular focus
on audit committees and regulations implemented in the wake of the
Sarbanes-Oxley Act of 2002.
Joseph H. Capper, President and Chief Executive Officer of
CardioNet, commented, “We are pleased to have Peter join the
CardioNet executive team. His expertise in securities matters,
corporate governance and mergers and acquisitions are highly
valuable to our Company, for both the immediate and long term. He
will provide important strategic leadership as we continue to grow
CardioNet into the world leader in wireless medicine.”
About CardioNet
CardioNet is a leading provider of ambulatory, continuous,
real-time outpatient management solutions for monitoring relevant
and timely clinical information regarding an individual’s health.
CardioNet’s initial efforts are focused on the diagnosis and
monitoring of cardiac arrhythmias, or heart rhythm disorders, with
a solution that it markets as Mobile Cardiac Outpatient TelemetryTM
(MCOT™). More information can be found at
http://www.cardionet.com.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024